Replies to post #226241 on Biotech Values

[jbog]

Enta will have trouble now. Hard to judge a price, but it certainly won't be at these levels.

[DaveAu]

It's kind of expensive when you can't test the theory before a phase 2A. The rats won't give up the answer and it seems healthy humans weren't all that bothered with it. I think they should concentrate on the other programs, RSV and HBV.